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BACKGROUND: Early spontaneous preterm delivery is often associ- had microbial invasion of the amniotic cavity. For spontaneous delivery
ated with microbial invasion of the amniotic cavity and/or intraamniotic
inflammation.
OBJECTIVE: The objective of the study was to develop and validate
clinically feasible multivariable prediction models of spontaneous delivery
within 7 days and microbial invasion of the amniotic cavity in women
admitted with diagnose of preterm labor and intact membranes below 34
weeks.
STUDYDESIGN:We used data from a cohort of women admitted from
2012 to 2018 with diagnosis of preterm labor below 34 weeks who had
undergone amniocentesis to rule out microbial invasion of the amniotic
cavity. The main outcome was spontaneous delivery within 7 days from
admission. The secondary outcome was microbial invasion of the amniotic
cavity, defined by a positive culture and/or 16S ribosomal RNA gene in the
amniotic fluid. The sample (n ¼ 358) was divided into derivation
(2012e2016) and validation cohorts (2017e2018). Logistic regression
models using a stepwise selection of variables were developed for the
outcomes evaluated. We explored as predictive variables ultrasound
cervical length measurement at admission, maternal C-reactive protein,
gestational age, amniotic fluid glucose, and interleukin-6 (expressed as
log units). Models were developed in the derivation cohort and applied to
the validation cohort and diagnostic performance was calculated.
RESULTS: The derivation cohort included 263 women and the valida-
tion cohort 95 women. One hundred five of the women (39%, 105 of 268)
spontaneously delivered in the following 7 days and 68 (19%, 68 of 358)Cite this article as: Cobo Teresa, Aldecoa V, Figueras F,
et al. Development and validation of a multivariable
prediction model of spontaneous preterm delivery and
microbial invasion of the amniotic cavity in women with
preterm labor. Am J Obstet Gynecol 2020;xxx;xx-xx
0002-9378/$36.00
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https://doi.org/10.1016/j.ajog.2020.02.049within 7 days after admission, 4 predictors were identified: cervical length
at admission, gestational age, amniotic fluid glucose, and interleukin-6.
The diagnostic performance of the model was assessed in the validation
cohort using the receiver operating characteristic curve and showed an
area under curve of 0.86 (95% confidence interval, 0.77e0.95) with a
detection rate of spontaneous delivery within 7 days of 87%, a false-
positive rate of 33%, a negative predictive value of 80%, and a negative
likelihood ratio of 0.1908. For microbial invasion of the amniotic cavity, 2
independent predictors of the amniotic cavity were identified: amniotic
fluid glucose and maternal C-reactive protein. The receiver operating
characteristic curve and an area under curve in the validation cohort was
0.83 (95% confidence interval, 0.70e0.96) with a detection rate of 76%,
a false-positive rate of 8%, a negative predictive value of 93%, and a
negative likelihood ratio of 0.2591.
CONCLUSION: In women with preterm labor, we propose 2 clinically
feasible prediction models to classify as low vs high risk of spontaneous
delivery within 7 days and of microbial invasion of the amniotic cavity. The
models showed a high diagnostic performance and could be of value to
optimize clinical management.
Key words: amniocentesis, cervical length, interleukin-6, intraamniotic
infection, intraamniotic inflammation, microbial invasion of the amniotic
cavity, multivariable prediction models, preterm birth, preterm labor,
spontaneous preterm deliveryne third of women who areO admitted to hospitals with a
diagnosis of preterm labor and intact
membranes (PTL) below 34 weeks will
deliver within the following 7 days.1,2
These cases are more often associated
with microbial invasion of the amnioticcavity (MIAC) and/or intraamniotic
inflammation (IAI).2e4
Identification of women with PTL at
high risk of delivery within 7 days and/or
of MIAC remains an unsolved clinical
challenge. Several ultrasound (US)5 and
biochemical markers6 have been pro-
posed as predictors of spontaneous pre-
term delivery within 7 days.7 Similarly,
amniotic fluid glucose8e12 or interleukin
(IL)-6 concentrations13e15 have been
strongly related to MIAC and/or IAI.
However, none of these markers have
shown enough accuracy to be used as
stand-alone predictors in clinical practice.
There is growing evidence suggesting
that multivariable predictionmodels canMONTH 2020 Amimprove the diagnostic performance of
different adverse outcomes such as pre-
eclampsia16 or fetal growth restriction.6
Concerning spontaneous preterm de-
livery, different prediction models have
been proposed. In women with PTL,
Carter et al17 developed and validated a
multivariable prediction model (QUiPP
app) that integrates maternal risk factors
(symptoms, previous cervical surgery,
previous preterm birth <37.0 weeks,
previous preterm prelabor rupture of
membranes, number of fetuses), US
(transvaginal ultrasound assessment of
cervical length), and biochemical
markers (cervicovaginal fluid quantita-
tive fetal fibronectin test results) toerican Journal of Obstetrics & Gynecology 1.e1
AJOG at a Glance
Why was the study conducted?
To develop feasible multivariable prediction models of spontaneous preterm
delivery within 7 days and microbial invasion of the amniotic cavity in women
with preterm labor
Key findings
The model to predict spontaneous preterm delivery within 7 days included
gestational age at admission, ultrasound cervical length measurement, amniotic
fluid glucose, and inteleukin-6 and showed an area under the curve of 0.86 (95%
confidence interval, 0.77e0.95) with a detection rate of spontaneous delivery
within 7 days of 87% and a false-positive rate of 33%. The model to predict
microbial invasion of the amniotic cavity included maternal C-reactive protein
and amniotic fluid glucose and showed an area under the curve of 0.83 (95%
confidence interval, 0.70e0.96) with a detection rate of 76% and a false-positive
rate of 8%.
What does this add to what is known?
The good diagnostic performance observed in these models might encourage
clinicians to integrate the use of the amniocentesis, particularly in women with
early preterm labor, to efficiently target the high-risk group of spontaneous de-
livery within 7 days and microbial invasion of the amniotic cavity, avoiding
unnecessary overtreatment if the risk is low.
Original Research OBSTETRICS ajog.orgpredict the occurrence of spontaneous
preterm delivery.17 However, the model
was not designed to predict IAI and/or
MIAC.
In this regard, other authors have
proposed different combinations of
proteomic biomarkers in the amniotic
fluid and in the cervicovaginal fluid18e20
with a good accuracy to predict MIAC
and/or IAI. These models have not been
properly validated20 or are not feasible to
be used as a tool for a rapid diagnosis in
the clinical setting.18,19
In this scenario, we aimed to develop
and validate clinically feasible multivar-
iable prediction models of both sponta-
neous delivery within 7 days after
admission and MIAC in women with
PTL below 34 weeks of gestation that can
be used in clinical decision making.
Material and Methods
Patient population
This retrospective, observational study
included consecutive women recruited
within a common research line for the
prediction of adverse outcomes in PTL
from 2012 to 2018 at the Hospital Clinic
and Hospital Sant Joan de Déu, Barce-
lona. As part of institutional clinical1.e2 American Journal of Obstetrics & Gynecologyprotocols, women with singleton preg-
nancies admitted with diagnosis of pre-
term labor and intact membranes below
34 weeks were offered an amniocentesis.
Women with the following conditions
were excluded: clinical signs of cho-
rioamnionitis21 at admission, cervical
length measurement at admission
greater than the fifth centile,2 maternal
age <18 years, and no consent to
perform amniocentesis for this indica-
tion. Maternal characteristics of women
who declined amniocentesis were similar
to our study population.
Patient selection and sampling pro-
cedures of both studies were performed
in accordance with the Declaration of
Helsinki and applicable local regulatory
requirements after approval from the
Institutional Review Boards (HCB/2010/
5811, HCB/2015/0367, PIC-82-15).
Written informed consent was obtained
for sample collection from all subjects.
The study group was divided into a
derivation cohort and a validation
cohort.
Clinical management
Standard management of women with a
diagnosis of PTL included USMONTH 2020transvaginal cervical length measure-
ment and maternal blood analysis for
evaluation of maternal C-reactive pro-
tein (CRP) and white blood cell count at
admission. Transvaginal cervical length
was measured by experienced staff
following Fetal Medicine Foundation
guidelines (htts://www.fetalmedicine.
com). Briefly, the vaginal probe was
placed approximately 3 cm from the
cervix to avoid pressure resulting in
distortion of the position and shape of
the cervix. A sagittal view of the full
length was measured by placing the cal-
ipers at the farthest points at which the
cervical walls were juxtaposed. Ultra-
sound cervical length was measured at
least 3 times and the shortest measure-
ment was recorded.
A complete course of antenatal ste-
roids, betamethasone 12 mg intramus-
cular injection with 2 doses given 24
hours apart, was administered until
34þ6 weeks for fetal lung maturation. If
there was no clinical contraindication,
tocolysis (nifedipine or atosiban) was
administered to prolong pregnancy
during steroid administration (a course
of 48 hours).
Broad-spectrum antibiotics (endove-
nous ampicillin 1 g every 6 hours and
gentamycin 80 mg every 8 hours and 1
dose of oral azithromycin 1 g) were
administered in women with amniotic
fluid glucose concentrations <5 mg/dL
and/or with microorganisms identified
by amniotic fluid Gram staining and/or
positive amniotic fluid cultures.
In women with advanced cervical
dilatation (Bishop >6), we also started
prophylactic broad-spectrum antibiotics
that were discontinued if amniotic fluid
cultures were negative. In the case of the
onset of uterine contractions after these
48 hours of steroid administration,
tocolysis was reintroduced only if MIAC
or clinical chorioamnionitis were
excluded.
Cultures for genital mycoplasma
(Mycoplasma IST 2, bioMérieux for
Ureaplasma spp or Mycoplasma homi-
nis), aerobic (chocolate agar), and
anaerobic (Schaedler agar for anaerobes
and thioglycollate broth) bacteria as well
as amniotic fluid glucose concentrations
and Gram stains were performed
ajog.org OBSTETRICS Original Researchimmediately after amniocentesis and
clinical management was made accord-
ing to the results.
Amniotic fluid samples were also
analyzed by specific polymerase chain
reaction (PCR) amplification of the 16S
ribosomal RNA gene using the primers:
5-AGA GTT TGA TCC TGG CTC AG-
3and 5-GGA CTA CCA GGG TAT CTA
AT-3 followed by Sanger sequencing in
the Department of Microbiology. Se-
quences were identified using the Blast
algorithm in the National Center for
Biotechnology Information database,
with a minimum 98% sequence identity.
Amniotic fluid IL-6 concentrations
were measured by enzyme-linked
immunoassay (Biosource; Invitrogen,
Carlsbad, CA) in amniotic fluid samples
previously centrifuged at 4000 rpm for
10 minutes at 4C and stored at e80C.
The minimum detectable level of IL-6
was 0.2 ng/mL.
Information of 16s ribosomal RNA
gene sequencing and IL-6 was not
available for clinical decision making.Classification of outcomes
The primary outcome was spontaneous
delivery within 7 days after admission.
Women who delivered because of
maternal or fetal indications were
consequently censored. The secondary
outcome was the occurrence of MIAC,
defined by the presence of a positive
amniotic fluid culture for bacteria, fungi,
and Ureaplasma spp or Mycoplasma
hominis and/or by specific PCR ampli-
fication of the 16S ribosomal RNA gene.
Gestational age was established accord-
ing to crown-rump length at the first-
trimester US scan.22
Predictors
Predictors used to develop multivariable
prediction model were those that
showed to be independent predictors in
the univariate logistic regression analysis
and included the following continuous
variables: US cervical length measure-
ment (millimeters) at admission,
maternal CRP concentrations (milli-
grams per liter), gestational age (weeks),
amniotic fluid glucose concentrations
(milligrams per deciliter), and amnioticfluid IL-6 (nanograms per milliliter)
(expressed in a log scale).
Sample size
The sample size23 to develop the multi-
variable prediction model was estab-
lished assuming an initial inclusion of 5
potential predictors selected a priori
based on consensus among the in-
vestigators (T.C., M.P., F.F., E.G.) and for
an outcome (delivery within 7 days after
admission) with a prevalence of 30%,1,2
resulting in a sample size of 167. To ac-
count for a proportion of censored cases
in which delivery is indicated electively
(30%) and 10% of cases with missing
information for any of the predictors, a
conservative number of 240 cases were
estimated.
For the validation cohort, all consec-
utive cases attended within 2 years
(2017e2018) after the model was
developed were included.
Statistical analysis
Statistical analysis was performed using
SPSS 20.0 for MAC OS (IBM Corpora-
tion, Armonk, NY). We compared
maternal characteristics and perinatal
outcomes between the derivation and
the validation cohorts; continuous vari-
ables were compared using a nonpara-
metric Mann-Whitney U test presented
as median with interquartile range (25th,
75th percentile). Categorical variables
were compared using the c2 or Fisher
exact test. Differences were considered
statistically significant with a value of P
< .05 with 2-sided alternative
hypotheses.
Multivariable analysis by stepwise lo-
gistic regression was used to identify
independent factors associated with the
outcomes (prediction model develop-
ment). The models that could best pre-
dict spontaneous delivery within 7 days
and MIAC were constructed based on
the final regression model and the di-
rection of effects. Goodness-of-fit
models were assessed by calculating
Nagelkerke’s R2.
Diagnostic performance was calcu-
lated (area under the receiver-operating
characteristic (AUROC) curve, sensi-
tivity, specificity, positive predictive
value, negative predictive value, positiveMONTH 2020 Amlikelihood ratio, and negative likelihood
ratio for spontaneous delivery within 7
days and for MIAC in the derivation and
the validation cohorts.
A posterior probabilities for a given
outcome were calculated using Fagan’s
plots (R statistics [R project; package
ggplot2]), in which a priori risk was
based on the prevalence of the outcome
among the sample population multi-
plied by the positive and negative likeli-
hoods ratios of the diagnostic test.
Finally, to assess the likelihood of pa-
tients to have significantly different re-
sults if receiving tocolysis based on their
clinical characteristics, we performed a
nearest-neighbor propensity score
matching by logit regression, in which
the outcome variable was spontaneous
delivery within 7 days after admission.
Predictor variables were gestational age
at admission, cervical length, amniotic
fluid glucose, and IL-6, and the treat-
ment variable was tocolysis. Test balance
for adequate matching was performed
using variance ratios.
Results
During the study period 531 women
were eligible for the study and 358 were
finally included. Figure 1 shows flow
chart of the entire study population.
For the overall population (n ¼ 358),
105 (39%, 105 of 268) of women spon-
taneously delivered in the following 7
days and 68 (19%, 68 of 358) had mi-
crobial invasion of the amniotic cavity.
Microorganisms isolated in the amniotic
fluid with their amniotic fluid IL-6
concentrations are presented in a sup-
plemental table (Supplemental Table 1).
The majority of women with MIAC
(60 of 67, 89.6%) had high levels of
amniotic fluid IL-6 (2.6 ng/mL).
Women with MIAC had an earlier
gestational age at admission (median
[25th, 75th percentiles], 26.4 [24.2, 30.5]
weeks) than women without (28.6 [25.6,
30.9] weeks). Gestational age at delivery
was significantly earlier in women with
MIAC (27 [25.1, 31.1] weeks) than in
women without (35.3 [30.3, 38.5]
weeks), and latency to delivery was
significantly shorter in women with
MIAC (1 [0, 3] day vs 35 [6, 64.5] days,
respectively).erican Journal of Obstetrics & Gynecology 1.e3
FIGURE 1
Distribution of the entire study group (2012e2018)
Final cohort
n=358
Singleton pregnancies with PTL <34.0 
weeks) 
n= 531
- Declined amniocentesis (n=88)
- Cervical length > 5th centile (n=35)
- Clinical chorioamnionitis at admission (n=40)
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weeks of gestation, 48% (59 of 123)
spontaneously delivered in the following
7 days, and 24.6% (41 of 167) hadMIAC.
Below 32 weeks of admission, the prev-
alence of spontaneous delivery within 7
days and MIAC was 38.7% (86 of 222)
and 19.1% (58 of 304), respectively.
Maternal characteristics and perinatal
outcome comparisons between women
with and without MIAC and with and
without sPTD within 7 days are pre-
sented in supplemental tables
(Supplemental Tables 2 and 3,
respectively).
The derivation cohort included 263
women and the validation cohort 95.
Differences in the maternal characteris-
tics and perinatal outcomes between
women from the derivation and the
validation cohorts are shown in Table 1.
In the validation cohort, IL-6 concen-
trations were significantly higher, gesta-
tional age at delivery was significantly
earlier and latency to delivery signifi-
cantly was shorter than in the derivation
cohort.
Multivariable analysis indicated that
gestational age at admission, cervical
length, amniotic fluid glucose, and IL-6
were independent predictors for spon-
taneous delivery within 7 days (Table 2).
Maternal CRP and amniotic fluid1.e4 American Journal of Obstetrics & Gynecologyglucose were independent predictors of
MIAC (P < .05).
The regression formula for sponta-
neous delivery within 7 days was:
e7.588 þ 0.132 * gestational age at
admissione 0.051 *US cervical lengthe
0.055 * amniotic fluid glucose þ 1.438 *
amniotic fluid log (IL-6). R2 ¼ 51.5%.
The regression formula for MIAC
was ¼ 1.034 þ 0.169 * maternal CRP
e0.158 * amniotic fluid glucose. R2 ¼
65.6%.
According to the selected predictors
and the direction of effects, we pro-
posed 2 models: one for spontaneous
delivery within 7 days and one for
MIAC in which maternal CRP ¼
milligrams per liter; amniotic fluid
glucose ¼ milligrams per deciliter;
gestational age at admission ¼ weeks;
US cervical length ¼ millimeters; and
amniotic fluid IL-6 (nanograms per
milliliter) were expressed in a log
scale.
The diagnostic performance of the
model for predicting spontaneous de-
livery within 7 days and MIAC was
assessed using ROC curves. The AUROC
of the model to predict the risk of
spontaneous delivery within 7 days was
0.88 (95% confidence interval [CI],
0.83e0.93) in the derivation cohort and
0.86 (95% CI, 0.77e0.95) in theMONTH 2020validation cohort. In the validation
cohort, the detection rate of sponta-
neous delivery within 7 days was of 87%
and the false-positive rate was 33%. We
selected a cutoff with a high detection
rate to efficiently target the high-risk
group of women who will inevitably
deliver in the following days.
The AUROC of the model for pre-
dicting MIAC was 0.94 (95% CI,
0.89e0.98) in the derivation and 0.83
(95% CI, 0.70e0.96) in the validation
cohort. In the validation cohort, the
detection rate of MIAC was 76% of
women, and the false-positive rate was of
8%. We decided to select a cutoff with a
low false-positive rate to avoid unnec-
essary antibiotic treatment in women
without MIAC. The diagnostic perfor-
mance of the 2 models is shown in
Table 3.
Figure 2 shows Fagan nomogram of
the validation cohort. According to this,
if we test the model for spontaneous
delivery within 7 days in a woman with a
priori risk of 57% this risk increases to
79% in the high-risk group (after
applying the positive LR value) and de-
creases to 20% in the low-risk group
(after applying the negative LR).
Regarding the risk of MIAC, if the priory
risk is 22%, it increases to 73% in the
high-risk group and decreases to 7% in
the low-risk group.
Our analysis (propensity score) to
account for an indication bias suggests a
lack of such effect because we did not
find tocolysis to be associated with




In this study, we developed and validated
clinically feasible multivariable predic-
tion models in women admitted with a
diagnosis of PTL below 34 weeks of
gestation that could help clinicians to
efficiently manage low- and high-risk
populations of spontaneous delivery
within 7 days and of MIAC.
The good diagnostic performance
observed in these models might
encourage clinicians to integrate the use
of the amniocentesis, considered a safe
procedure, even in a more challenging
TABLE 1
Maternal characteristics and perinatal outcomes of the women in the derivation and the validation cohorts
Variables Derivation cohort (n ¼ 263) Validation cohort (n ¼ 95) P value
Maternal age, y 33.1 (28.1, 36.5) 34.2 (29.0, 37.9) .069
Caucasian ethnicity 190 (72) 59 (62) < .001
Smoking 30/203 (15) 13 (14) .861
Nulliparity 123 (47) 58 (61) 0.023
Prior preterm birth 34 (13) 3 (3) .006
Cervical length, mm 11 (5; 18) 9 (3; 15) .149
CRP, mg/L 0.75 (0.38, 1.98) 1.06 (0.49, 2.48) .087
WBC (109/L) 12,280 (10,230, 14,940) 12,330 (10,710, 15,800) .517
GA at admission, wks 28.6 (25.3, 31.0) 27.4 (24.4, 30.4) .084
GA at amniocentesis, wks 28.6 (25.4, 31.0) 27.4 (24.6, 30.6) .093
AF glucose, mg/dL 31 (18, 43) 26 (13, 39) .140
AF IL-6, ng/mL 2.47 (1.02, 20.8) 16.95 (2.2, 121.4) < .001
MIAC 47 (18) 21 (22) .364
Antenatal steroids 232/247 (94) 85 (90) .168
Antenatal antibiotics 149 (57) 62/94 (66) .142
GA at delivery, wks 34.6 (29.1, 38.3) 31 (26.7, 36) .001
GA <37.0 weeks 163 (62) 74 (78) .005
Spontaneous onset of labor 201 (76) 67 (71) .271
Spontaneous delivery within 48 h after admission 34/201 (17) 17/67 (25) .158
Spontaneous delivery within 7 days after admission 67/201 (33) 38/67 (57) .001
Latency to delivery, d 31 (3; 62) 7 (1; 50) .004
Clinical chorioamnionitis at delivery 37/262 (14) 29/87 (33) < .001
Continuous variables were compared using a nonparametric Mann-Whitney U test presented as medians (25th and 75th interquartile percentiles). Categorical variables were compared using c2 or
Fisher exact tests and presented as number (percentage).
AF, amniotic fluid; CRP, C-reactive protein; GA, gestational age; MIAC, microbial invasion of the amniotic cavity; WBC, white blood cells.
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rupture of membranes,24 as part of the
management of PTL, particularly in
women with early PTL (eg, before 32
weeks).
Results
Prediction models of spontaneous de-
livery within 7 days after admission have
previously been proposed in symptom-
atic25 women. Thus, Carter et al17
developed and validated a multivariable
prediction model (QUiPP app) in
women with symptoms of PTL showing
similar diagnostic performance to our
prediction model with the strength to be
a minimally invasive tool. However,
what is of note in Carter et al17 paper isthe low prevalence of spontaneous de-
livery within 7 days reported in their
validation cohort (4.9% vs 57%
observed in our cohort).
Based on these differences, we might
hypothesize that QUiPP app was used by
the authors as a screening tool to in-
crease confidence in the admission de-
cision of women attending with
symptoms. In our admission decision,
we are already performing a QUiPP-like
screening because we take into consid-
eration gestational age and cervical
length. This explains the high rate of
spontaneous delivery within 7 days
observed in our validation cohort. What
differentiates our model from QUiPP
app is that our model was developed notMONTH 2020 Amto be a screening tool but to be a diag-
nostic tool of spontaneous delivery
within 7 days.
Our model integrates not only
maternal (gestational age) and US fac-
tors (cervical length measurement), as
QUiPP app does, but also information
related to IAI (amniotic fluid glucose
and IL-6). To include information
related to IAI in a prediction model of
spontaneous delivery within 7 days leads
to a better prognosis and more efficient
clinical management. Up to 40% of
women with early diagnosis of PTL (<
28 weeks) have IAI (with or without
MIAC2e4). In addition, early sponta-
neous preterm delivery2 is considered to
most likely be related to thiserican Journal of Obstetrics & Gynecology 1.e5
TABLE 2







P valueOR 95% CI OR 95% CI
GA at amniocentesis, wks 1.141 1.007e1.292 .038 CRP (mg/L) 1.184 1.017e1.380 .030
Cervical length, mm 0.951 0.913e0.990 .014 AF glucose (mg/dL) 0.854 0.816e0.893 < .001
AF glucose, mg/dL 0.947 0.921e0.973 < .001
AF IL-6 (log) 4.211 2.316e7.657 < .001
AF, amniotic fluid; CI, confidence interval; CRP, C-reactive protein; IL-6, interleukin-6; MIAC, microbial invasion of the amniotic cavity; OR, odds ratio.
Cobo et al. Prediction models of spontaneous preterm delivery and microbial invasion of the amniotic cavity in preterm labor. Am J Obstet Gynecol 2020.
Original Research OBSTETRICS ajog.orginflammatory condition. Finally, there
has been widely reported the association
of IAI with a worse perinatal
outcome.3,4,26
There have been other authors who
proposed a prediction model of sponta-
neous preterm delivery including IAI
information. Thus, Holst et al27 pro-
posed a good model to predict sponta-
neous delivery within 7 days including a
combination of amniotic fluid and cer-
vical fluid inflammatory proteins using
multiplexed immunoassay technology.
However, these results were not vali-
dated in an independent cohort, thus
limiting the reproducibility of their
findings. Similarly, Hitti et al19 andTABLE 3






AUC (95% CI) 0.88
Sensitivity n (%) 55/67
Specificity n (%) 114/134
Positive predictive value n (%) 55/75
Negative predictive value n (%) 114/126
Positive LR 4.53
Negative LR 0.1838
AUC, area under curve; CI, confidence interval; LR, likelihood ra
Cobo et al. Prediction models of spontaneous preterm delive
1.e6 American Journal of Obstetrics & GynecologyCombs et al18 developed and validated 2
different predictive models of MIAC in
women with PTL including different
proteins measured in the cervicovaginal
fluid. The main limitation is that such
protein measures are not readily avail-
able in clinical laboratories.
Conversely, we propose clinically
feasible prediction models that can be
used in clinical decision making. Indeed,
all the variables included in the models
reported here can be measured imme-
diately after admission (such as gesta-
tional age, US cervical length) or within a
few hours (eg, maternal CRP, amniotic
fluid glucose). There are currently even
IL-6 bedside tests13e15 that provide rapidpontaneous delivery within 7 days after a
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tio; MIAC: microbial invasion of the amniotic cavity.
ry and microbial invasion of the amniotic cavity in preterm labo
MONTH 2020information and show a good correla-
tion with the gold standard enzyme-
linked immunoassay analysis.
Clinical implications
For a clinical perspective, the classifica-
tion of the risk of spontaneous delivery
within 7 days and/or MIAC into low and
high risk might help clinicians to more
efficiently manage women with diag-
nosis of PTL. In the high-risk group,
expected early delivery should be plan-
ned with antenatal strategies that have
shown to improve neonatal outcome,
such as patient transfer to facilities with
neonatal intensive care units, treatment
with antenatal steroids28 anddmission in the derivation and the
C
rivation
ort (n ¼ 263)
Validation
cohort (n ¼ 95)
0.94 (0.89e0.98) 0.83 (0.70e0.96)
39/47 (82.98) 16/21 (76.19)
7/216 (95.83) 68/74 (91.89)
39/48 (81.25) 16/22 (72.73)
7/215 (96.28) 68/73 (93.15)
.91 9.40
776 0.2591
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protection,29 and, for those with MIAC,
early initiation of broad-spectrum
antibiotics.30
In this regard, although systematic
antenatal antibiotic prophylaxis has been
questioned in women with PTL,31,32
emerging data suggest that eradication
of MIAC and IAI is possible in a sub-
stantial number of women with PTL af-
ter early administration of broad-
spectrum antibiotic treatment.30
With respect to the low-risk group,
the management of these women could
be potentially ameliorated with a lower-
level intensity intervention.
Research implications
Future studies are required to prospec-
tively evaluate the influence of these
models on improving clinical manage-
ment and the potential benefit of early
antibiotic treatment in women with ahigh-predicted risk of MIAC. Studies
evaluating the cost-effectiveness of our
models (eg, hospital stay length, cost of
treatment, or work leave) are also
warranted.
Strengths and limitations
A main strength of this study is that the
model was validated in an independent
sample. We included a well-
characterized large cohort with infor-
mation ofMIAC and with close perinatal
follow-up. Moreover, the diagnosis of
MIAC was based on microbial cultures
as well as PCR targeting the 16S ribo-
somal RNA gene sequence. Moreover, all
the predictors included in the 2 models
are variables that can be obtained at
admission or within 24 hours in most
clinical settings.
Finally, we evaluated whether clinical
management with tocolysis interfered
with the outcome of spontaneousMONTH 2020 Amdelivery within 7 days in some women
(eg, discontinuation of tocolysis if am-
niotic fluid cultures were positive or
glucose was <5 mg/dL) and found no
association between them
(Supplemental Table 1). This might be
due to the fact that, regardless of our
management, these women with MIAC
will inevitably deliver in few days
because of the inflammatory
exposition.3,4,26
As limitations, IL-6 was measured in
frozen samples, although there is strong
evidence showing a good correlation
between frozen and fresh samples.13,28
Finally, this study was not designed to
evaluate whether our prediction models
improve maternal and neonatal
outcomes.
Conclusion
In conclusion, we propose 2 clinically
feasible multivariable prediction modelserican Journal of Obstetrics & Gynecology 1.e7
Original Research OBSTETRICS ajog.orgthat may help clinicians to individualize
the management of women admitted
with a diagnose of PTL before 34 weeks
of gestation: first, targeting the high-risk
group of spontaneous delivery within 7
days after admission and/or of MIAC
who require efficient planning of ex-
pected early delivery; and second,
avoiding unnecessary overtreatment in
the low-risk group. n
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SUPPLEMENTAL TABLE 1
Information about microorganisms isolated in the amniotic fluid
Variables Microorganisms in the amniotic fluid AF IL-6, ng/mL Latency to delivery, d
1 Ureaplasma spp 0.102 3.00
2 Ureaplasma spp 20.106 15.00
3 Ureaplasma spp 90.832 1.00
4 Ureaplasma spp 892.642 15.00
5 Ureaplasma spp 22.891 1.00
6 Ureaplasma spp 1.799 6.00
7 Ureaplasma spp 133.250 1.00
8 Ureaplasma spp 158.600 1.00
9 Ureaplasma spp 37.760 1.00
10 Ureaplasma spp 4.306 3.00
11 Ureaplasma spp 9.005 1.00
12 Ureaplasma spp 0.376 13.00
13 Ureaplasma spp 3.736 2.00
14 Ureaplasma sp., Streptococcus anginosus 161.051 1.00
15 Ureaplasma spp, Fusobacterium spp 24.522 0.00
16 Ureaplasma spp 236.856 1.00
17 Ureaplasma spp 80.7325 12.00
18 Ureaplasma spp 75.7254 1.00
19 Ureaplasma spp 838.025 4.00
20 Ureaplasma spp 148.620 0.00
21 Ureaplasma spp 151.632 3.00
22 Ureaplasma spp 125.220 1.00
23 Ureaplasma spp 26.7074 4.00
24 Ureaplasma spp 48.1035 2.00
25 Ureaplasma spp 139.401 3.00
26 Ureaplasma spp 152.103 3.00
27 Ureaplasma spp 1214.000 3.00
28 Ureaplasma spp, Haemophilus influenzae 207.199 .00
29 Ureaplasma spp., Mycoplasma hominis 340.687 1.00
30 Ureaplasma spp, Fusobacterium spp, Candida albicans 24.432 2.00
31 Ureaplasma spp 41.151 36.00
32 Mycoplasma hominis 598.0 0.00
33 Mycoplasma hominis, Fusobacterium spp 30.313 2.00
34 Fusobacterium spp 2.774 0.00
35 Fusobacterium nucleatum 1888.000 17.00
36 Fusobacterium spp 2.790 0.00
37 Fusobacterium spp 44.420 3.00
38 Fusobacterium nucleatum 591.869 1.00
39 Fusobacterium nucleatum 789.989 0.00
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SUPPLEMENTAL TABLE 1
Information about microorganisms isolated in the amniotic fluid (continued)
Variables Microorganisms in the amniotic fluid AF IL-6, ng/mL Latency to delivery, d
40 Fusobacterium nucleatum 1595.000 2.00
41 Fusobacterium spp 498.415 0.00
42 Fusobacterium nucleatum 837.164 5.00
43 Fusobacterium nucleatum, Streptococcus viridans 2879.000 0.00
44 Fusobacterium spp, Candida albicans 1332.000 1.00
45 Fusobacterium nucleatum, Candida albicans 0.339 1.00
46 Streptococcus viridans 2.829 1.00
47 Streptococcus agalactiae, Candida albicans 2.460 2.00
48 Streptococcus mitis 1.176 53.00
49 Streptococcus pyogenes 0.2627 46.00
50 Streptococcus agalactiae 542.438 0.00
51 Listeria monocytogenes 242.202 3.00
52 Listeria monocytogenes 18.151 0.00
53 Listeria monocytogenes 127.575 0.00
54 Lactobacillus 28.060 11.00
55 Lactobacillus 118.842 1.00
56 Escherichia coli 281.509 0.00
57 Escherichia coli 2.8948 0.00
58 Escherichia coli 20.8493 0.00
59 Capnocytophaga sputigena 38.480 1.00
60 Capnocytophaga sputigena 123.386 0.00
61 Candida albicans 142.649 0.00
62 Candida albicans 6.020 2.00
63 Candida albicans 14.720 7.00
64 Leptotrichia spp 262.367 1.00
65 Proteus mirabilis 48.940 1.00
66 Prevotella amnii 413.000 1.00
67 Peptostreptococcus 36.499 0.00
68 Bacteroides fragilis 696.715 0.00
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SUPPLEMENTAL TABLE 2
Maternal characteristics and perinatal outcomes according to the outcome of MIAC
Variables MIAC (n ¼ 68) No MIAC (n ¼ 290) P value
Maternal age, y 33.3 (26.3, 36.5) 31.8 (27.9, 36.3) .233
White ethnicity 47 (69) 202 (70) .541
Smoking 8/59 (14) 35/239 (15) 1.000
Nulliparity 35 (52) 146 (50) .893
Prior preterm birth 6 (9) 31 (11) .825
Cervical length, mm 5 (0, 14) 11 (5;18) .002
CRP, mg/L 3.4 (1.1, 7.3) 0.6 (0.3, 1.4) < .001
WBC (109/L) 14,110 (12,085, 1,7285) 12,090 (9890, 14,720) < .001
GA at admission, wks 26.4 (24.8, 30.5) 28.6 (25.7, 31.0) .017
GA at amniocentesis, wks 26.4 (24,8, 30.5) 28.6 (25.7, 31.0) .018
AF glucose, mg/dL 4 (0, 6) 33 (24, 44) < .001
AF IL-6, ng/mL 48.1 (10.4, 273.9) 2.2 (0.9, 10.6) < .001
Antenatal steroids 57/59 (97) 260/283 (92) .276
Antenatal antibiotics 66 (97) 145/289 (50) < .001
GA at delivery, wks 26.9 (25.2, 31.1) 35.0 (29.7, 38.3) < .001
Spontaneous onset of labor 49 (72) 219 (76) .539
Latency to delivery, d 1 (0, 3) 31 (6, 62) < .001
Clinical chorioamnionitis at delivery 39/66 (59) 27/283 (10) < .001
Continuous variables were compared using a nonparametric Mann-Whitney U test presented as medians (25th and 75th interquartile percentiles). Categorical variables were compared using c2 or
Fisher exact tests and presented as number (percentage).
AF, amniotic fluid; CRP, C-reactive protein; GA, gestational age; MIAC, microbial invasion of the amniotic cavity; WBC, white blood cells.
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SUPPLEMENTAL TABLE 3
Maternal characteristics and perinatal outcomes according to the outcome of sPTD within 7 days
Variables sPTD, 7 d (n ¼ 105) No sPTD, 7 d (n ¼ 163) P value
Maternal age, y 33.0 (27.6, 36.8) 31.9 (27.6, 36.3) .554
White ethnicity 70 (67) 121 (74) .167
Smoking 21/98 (21) 10/126 (8) .006
Nulliparity 58 (55) 80 (49) .381
Prior preterm birth 12 (11) 18 (11) 1.000
Cervical length, mm 6 (0, 16) 11 (6, 18) < .001
CRP, mg/L 1.8 (0.7, 4.4) 0.5 (0.3, 1.1) < .001
WBC (109/L 14040 (11875, 17340) 11540 (9700, 14080) < .001
GA at admission, wks 27.4 (25.0, 31.0) 28.9 (26.0, 31.0) .148
GA at amniocentesis, wks 27.4 (25.0, 31.0) 29.0 (26.0, 31.0) .171
AF glucose, mg/dL 16 (3.5, 30) 36 (26, 46) < .001
AF IL-6, ng/mL 32.0 (4.5, 127.6) 1.3 (0.8, 2.89) < .001
Antenatal steroids 97/99 (98) 147/160 (92) .054
Antenatal antibiotics 95 (91) 66/162 (41) < .001
GA at delivery, wks 27.4 (25.1, 31.3) 37.3 (33.0, 38.9) < .001
Spontaneous onset of labor 105 (100) 163 (100) —
Latency to delivery, d 2 (1, 3) 49 (27, 72) < .001
Clinical chorioamnionitis at delivery 37/99 (37) 10/162 (6) < .001
Continuous variables were compared using a nonparametric Mann-Whitney U test presented as medians (25th and 75th interquartile percentiles). Categorical variables were compared using c2 or
Fisher exact tests and presented as number (percentage).
AF, amniotic fluid; CRP, C-reactive protein; GA, gestational age; MIAC, microbial invasion of the amniotic cavity; WBC, white blood cells.
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SUPPLEMENTAL TABLE 4
Association between model variables for prediction of spontaneous preterm delivery at 7 days after nearest neighbor
propensity score matching
Outcome GA at admission Cervical length AF glucose AF IL-6
sPTD within 7 days Coefficient (95% CI)
No tocolysis (n ¼ 10) Reference Reference Reference Reference
Tocolysis (n ¼ 84) 0.016 (e0.032 to 0.062) e0.025 (e0.06 to 0.01) e0.001 (0.17e0.02) e0.49 (e0.13 to 0.31)
Estimated average treatment effect in population comparing tocolysis vs. no tocolysis
Outcome Coefficient SE 95% CI P value
sPTD within 7 days 0.22 0.2 e0.18 to 0.62 0.285
AF, amniotic fluid; CI, confidence interval; GA, gestational age; IL, interleukin; sPTD, spontaneous preterm delivery.
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